Free accessCase reportFirst published online 2006-10
Immune Recovery following Antineoplastic Chemotherapy and Highly Active Antiretroviral Therapy (Haart) in a Child with HIV-1 Infection Previously Unresponsive to Haart
We report the case of a perinatally HIV-1-infected child, previously immunologically unresponsive to antiretroviral treatments (including the highly active antiretroviral therapy), who instead developed a vigorous and long-lasting immune response after the highly active antiretroviral therapy was associated with antineoplastic chemotherapy undertaken for a B-cell non-Hodgkin bone lymphoma.
FraternaleA.CasabiancaA.OrlandiC.ChiarantiniL.BrandiG.SilvestriG.MagnaniM., 2002. Repeated cycles of alternate administration of fludarabine and Zidovudine plus Didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels. Virology302:354.
2.
Italian Register for HIV Infection in Children. 1999. Italian guidelines for antiretroviral therapy in children with human immunodeficiency virus-type 1 infection. Acta Paediatr. 88:228.
3.
ReiterA.SchrappeM.ParwareschR.HenzeG.Muller-WeihrichS.SauterS.SykoraK.W.LudwigW.D.GadnerH.RiehmH., 1995. Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage- a report of the Berlin-Frankfurt-Munster Group. J. Clin. Oncol.13:359.
4.
CaselliD.KlersyC.de MartinoM.GabianoC.GalliL.TovoP.A.AricòM.2000. Human Immunodeficiency virus-related cancer in children: Incidence and treatment outcome - Report of the Italian Register on HIV infection in children. J. Clin. Oncol.18:3854.
5.
SimonelliC.ZanussiC.CinelliR.Dal MasoL.Di GennaroG.D'AndreaM.NastiG.SpinaM.VaccherE.De PaoliP.TirelliU., 2003. Impact of concomitant antiblastic chemotherapy and highly active antiretroviral therapy on human immunodeficiency virus (HIV) viremia and genotyping in HIV-infected patients with non-Hodgkin lymphoma. Clin. Infect. Dis.37:820.
6.
RatnerL.LeeJ.TangS.ReddenD.HamsehF.HerndierB.ScaddenD.KaplanL.AmbinderR.LevineA.HarringtonW.GrochowL.FlexnerC.TanB.StrausD., 2001. Chemotherapy for human immunodeficiency virus-associated non Hodgkin lymphoma in combination with highly active antiretroviral therapy. J. Clin. Oncol.19:2171.
7.
LoriF.JessenH.LiebermanJ.ClericiM.TinelliC.LisziewiczJ., 1999. Immune restoration by combination of a cytostatic drug (hydroxyurea) and anti-HIV drugs (didanosine and indinavir). AIDS Res. Hum. Retroviruses15:619.
8.
LoriF.FoliA.GroffA.LovaL.WhitmanL.BakareN.PollardR.B.LisziewiczJ., 2005. Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic (‘virostatic’) mechanisms. AIDS19:1173.
9.
HerbortC.P.ChaveJ.P., 1998. Cicatrization of cytomegalovirus retinitis following introduction of highly active anti-retroviral therapy: Uveitis as a possible indicator of good ocular prognosis. Graefes Arch. Clin. Exp. Ophtamol.236:795.
10.
De RossiA.WalkerA.S.KleinN.De ForniD.KingD.GibbD.M., 2002. Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency type 1-infected children in the Pediatric European Network for Treatment of AIDS (PENTA) 5 trial. J. Infect. Dis.186:312.
11.
FrancoJ.M.Leon-LealJ.A.LealM.Cano-RodriguezA.PinedaJ.A.MaciasJ.RubioA.ReyC.SanchezB.LissenE., 2000. CD4+ and CD8+ T lymphocyte regeneration after antiretroviral therapy in HIV-1-infected children and adult patients. Clin. Exp. Immunol.119:493
